Thomas W. Concannon

Photo of Thomas Concannon
Senior Policy Researcher
Boston Office


Ph.D. in health policy and administration, Harvard University; M.A. in political science, McGill University; B.A. in political science, University of Massachusetts

Media Resources

This researcher is available for interviews.

To arrange an interview, contact the RAND Office of Media Relations at (310) 451-6913, or email

More Experts


Thomas Concannon is a senior policy researcher at the RAND Corporation, assistant professor of medicine at Tufts University School of Medicine (2006-present), and director of Stakeholder and Community Engagement at Tufts Clinical and Translational Science Institute (2015-present). For more than 25 years, Concannon has collaborated with patients, clinicians and other stakeholders in health care and research. Concannon pursues two major research interests: (1) delivery, access, and use of specialty care, including in burns, cardiovascular, and orthopedic health services, (2) involvement of patients, clinicians, and other stakeholders in clinical and translational science. He is committed to improving the usefulness of research in policy decisions. He leads several large evaluations of CMS, CMMI, and CDC programs and service delivery models. He has published frameworks aimed at improving the translation of clinical and health systems research through use of pragmatic, rapid-cycle, and stakeholder-engagement approaches. 

Concannon earned his Ph.D. in health policy at Harvard University and his M.A. in political science at McGill University.

Concurrent Non-RAND Positions

Assistant Professor, Tufts University School of Medicine; Director, Stakeholder and Community Engagement Program, Tufts Clinical and Translational Sciences Institute

Recent Projects

  • Stakeholder Views on Patient-Centered Comparative Effectiveness Research
  • Chicago Area Patient-Centered Outcomes Research Network
  • Tufts Clinical and Translational Science Institute
  • Veterans Affairs Accountability and Choice Act Assessments

Selected Publications

Concannon TW, Guise JM, Dolor RJ, Meissner P, Krishnan JA, Pace WD, Saltz J, Hersh W, Michener L Carey TS, "A national strategy to develop pragmatic clinical trials infrastructure," Clinical and Translational Science, 7(2), 2014

Concannon TW, Saunders T, Fuster M, Patel K, Wong JB, Leslie LK, Lau J, "A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research," Journal of General Internal Medicine, 29(12), 2014

Concannon TW, Nelson J, Kent DM, Griffith JL, "Evidence of systematic duplication by new percutaneous coronary intervention programs," Circulation: Cardiovascular Quality and Outcomes, 6(4), 2013

Concannon TW, Meissner P, Grunbaum JA, McElwee N, Guise JM, Santa J, Conway PH, Daudelin D, Morrato EH, Leslie LK, "A new taxonomy for stakeholder engagement in patient centered outcomes research," Journal of General Internal Medicine, 27(8), 2012

Concannon TW, Nelson J, Goetz J, Griffith JL, "A percutaneous coronary intervention lab in every hospital?" Circulation: Cardiovascular Quality and Outcomes, 5(1), 2012


  • Closeup of hands of a Black doctor shaking hands with a white patient, photo by LumiNola/Getty Images

    Patients Should Have a Role in Deciding the Value of Medicines

    Patients, their family members, and the general public have historically been excluded from contributing to health care value assessment models. But methods for including patient voices in research are far less complicated or demanding than some researchers believe they will be.

    Jul 10, 2020 STAT

  • A doctor sitting at a desk, using a laptop

    What Makes Stakeholders Want to Become Involved in Research?

    Involving stakeholders in comparative-effectiveness research is important. But competing demands for their time can make this a challenge. Why do stakeholders get involved in this research, or not?

    May 2, 2016 The RAND Blog

  • Medical professionals discussing research

    What Do Stakeholders Say About Comparative-Effectiveness Research?

    Insurers, employers, and industry are some of the stakeholder groups that are critical to the success of comparative-effectiveness research. Current research models may not provide stakeholders with all the information they need to support their involvement.

    Apr 25, 2016 The RAND Blog

  • Medical staff helping senior woman walk with a walker

    More Research Is Needed on Artificial Joints and Patients Can Play a Key Role

    Safety problems with artificial knees and hips, including product recalls, highlight the need for more patient-centered research. RAND has partnered with CreakyJoints in a project intended to train a group of patients to get involved in research on this topic.

    Jan 22, 2016 Bloomer Boomer

  • A doctor explaining something on a tablet to her patient

    Can Patient-Centered Outcomes Research Improve Health Care?

    A review in 2017 of the adequacy and use of Patient-Centered Outcomes Research Trust Funds will be used to determine whether funding levels should be continued or adjusted after its authorization runs out in 2019. Researchers ought to take stock of the work in patient-centered outcomes research.

    Jul 31, 2015 The BMJ